Sort
34,240 grants matching “atherosclerosis”
The paradoxical role of CDKN2B in blood vessel sprouting and maturation
$476,710Nicholas James Leeper · Stanford University · R01 · FY2015 · HL
Determinants of Shear Stress-Mediated Arterial Remodeling
$476,686Joseph A. Vita · Boston University Medical Campus · R01 · FY2007 · HL
ENDOTHELIAL MODIFICATIONS THAT REDUCE T CELL ACTIVATION
$476,650Yale University · R01 · FY2002 · HL
Regulation of CNS leukocyte extravasation
$476,636Joel S Pachter · University Of Connecticut Sch Of Med/Dnt · R01 · FY2019 · NS
Biomechanical Simulation of Evolving Aortic Aneurysms for Designing Intervention
$476,605Jay D Humphrey · Texas Engineering Experiment Station · R01 · FY2008 · HL
DIET, ENDOTHELIAL FUNCTION AND PEDIATRIC HYPERLIPIDEMIA
$476,410University Of California San Francisco · R01 · FY2001 · NR
Project 2: Regulation of lipid and glucose metabolism by ANGPTL3 in humans
$476,409Nathan Oliver Stitziel · University Of Washington · P01 · FY2023 · HL
Inducible Macrophage Specific Gene Expression in Diseases
$476,359Jeanine M D'armiento · Columbia University Health Sciences · RC1 · FY2009 · HL
Cell-Selective Therapies for Coronary Artery Disease
$476,323Hana Totary-Jain · University Of South Florida · R01 · FY2024 · HL
Project 4: Diabetes-induced Myeloid Cell Activation, HDL and Atherosclerosis
$476,269Karin E. Bornfeldt · University Of Washington · P01 · FY2015 · HL
In Vivo Molecular MRI of Atherothrombotic Lesions
$476,261Zahi A. Fayad · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · HL
2/2 REPRIEVE Extension for Trial Completion
$476,233Michael Tse-Yin Lu · Massachusetts General Hospital · U24 · FY2025 · HL
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
$476,180Weidong Wang · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · DK
Progression of sub-clinical Atherosclerosis
$476,169Joseph F Polak · Tufts Medical Center · R01 · FY2009 · HL
GENCAC - Minnesota Field Center
$476,162University Of Minnesota Twin Cities · U01 · FY2002 · HL
PROTEIN Z DEPENDENT PROTEINASE INHIBITOR
$476,143George J Broze · Washington University · R01 · FY2009 · HL
Neurotoxicity of Airborne Particles: Role of Chronic Cerebral Hypoperfusion
$476,090William J Mack · University Of Southern California · R01 · FY2016 · ES
GPCR Signaling and Vascular Wall Remodeling
$475,866Gadiparthi N Rao · University Of Tennessee Health Sci Ctr · R01 · FY2018 · HL
GPCR Signaling and Vascular Wall Remodeling
$475,866Gadiparthi N Rao · University Of Tennessee Health Sci Ctr · R01 · FY2017 · HL
GPCR Signaling and Vascular Wall Remodeling
$475,866Gadiparthi N Rao · University Of Tennessee Health Sci Ctr · R01 · FY2019 · HL
Diabetes Prevention Program Outcomes Study - Phase 2
$475,716Karol E Watson · University Of California Los Angeles · U01 · FY2011 · DK
Genomic Approaches to Common Chronic Disease
$475,577Alan Robert Templeton · University Of Michigan At Ann Arbor · P50 · FY2011 · GM
Regulation of X-chromosome inactivation and imprinting by non-coding elements
$475,535Jeannie T Lee · Massachusetts General Hospital · R01 · FY2022 · GM
Regulation of X-chromosome inactivation and imprinting by non-coding elements
$475,535Jeannie T Lee · Massachusetts General Hospital · R01 · FY2025 · GM
Regulation of X-chromosome inactivation and imprinting by non-coding elements
$475,535Jeannie T Lee · Massachusetts General Hospital · R01 · FY2024 · GM